Disparate Intent-to-Treat Outcomes for Pediatric Liver Transplantation Based on Indication

Table 5

Multivariable analysis: post-transplant mortality.

Variable	Post-transplant mortality
	value	95% CI	Hazard ratio
Age	0	1.01–1.04	1.03
Indication
Hepatoblastoma	0	2.69–5.32	3.78
Autoimmune cirrhosis	0.02	1.13–3.28	1.92
AHN	0	1.19–2.35	1.68
Metabolic disorders	0.70	0.74–1.55	1.07
Other	0	1.58–2.59	2.02
Race and ethnicity
White	0.10	0.69–1.03	0.84
Black	0.66	0.74–1.20	0.94
Height (cm)
Donor-recipient height difference over 60 cm	0.96	0.80–1.23	0.99
Life support	0	1.77–2.96	2.29
Dialysis	0	1.31–3.15	2.03
Insurance
Private	0.82	0.70–1.31	0.96
Public	0.03	1.04–1.90	1.40
Status 1	0.74	0.75–1.22	0.95
Region
CA, NV, AZ, UT, NM	<0.05	0.63–1.00	0.79
AK, HI, ID, MT, OR, WA	0.04	0.25–0.96	0.49
Initial laboratory values
Bilirubin	0.31	0.99–1.01	1.00
INR	0.41	0.97–1.08	1.02
Creatinine	0.09	0.95–1.81	1.31
Albumin	0	0.70–0.89	0.78